SELENA HOOTS: Open Payments
NPI 1942710769 · DAYTONA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$748 in 32 payments from 13 companies in 2025. Trend: 2023 $911 · 2024 $747 · 2025 $748
Food & beverage: $748
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $181 |
| Novartis Pharmaceuticals Corporation | 7 | $151 |
| Janssen Biotech, Inc. | 4 | $98 |
| BeOne Medicines USA, Inc. | 3 | $87 |
| Gilead Sciences, Inc. | 2 | $46 |
| Lilly USA, LLC | 1 | $32 |
| TAIHO ONCOLOGY, INC. | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Deciphera Pharmaceuticals Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $21 |
Products named: ENHERTU, KISQALI, TALVEY, BRUKINSA, Trodelvy, RYBREVANT, TEVIMBRA, VERZENIO.
Industry payments across FL — which companies pay providers there.
